Automated, label-free TCID50 assay to determine the infectious titer of virus-based therapeutics

Daniel Hochdorfer(Boehringer Ingelheim (Germany)), Johannes Solzin(Boehringer Ingelheim (Germany)), Carina Seifried(Boehringer Ingelheim (Germany)), Ramona Businger(Boehringer Ingelheim (Germany)), Dominik Hotter(Boehringer Ingelheim (Germany))
Journal of Virological Methods
October 7, 2021
Cited by 31


Related Papers